The current impact on Pharma and Life Sciences companies varies heavily by category as patients need life-saving drugs and devices. Some Pharmaceutical and Medical Device companies are faced with demand surge to manufacture consumables, sanitizers, and diagnostic kits for testing patients globally while struggling to overcome disruptions in their supply chain.
Biologics/vaccines companies are working with regulatory agency around the globe via fast track approval process to deliver cure to patients as early as possible. Visibility of inventory for life saving drugs and devices is critical for public health. Specifically, adjusting plans and strategies in the immediate near-term, and possibly to the end of year, will prove to be a major challenge.